Bio-Techne Corp
NASDAQ:TECH
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Bio-Techne Corp
NASDAQ:TECH
|
US |
|
M
|
Mida Leasing PCL
SET:ML
|
TH |
|
Pintec Technology Holdings Ltd
NASDAQ:PT
|
CN |
|
C
|
Carindale Property Trust
ASX:CDP
|
AU |
|
Dr Martens PLC
LSE:DOCS
|
UK |
|
Brainstorm Cell Therapeutics Inc
NASDAQ:BCLI
|
US |
|
American Water Works Company Inc
NYSE:AWK
|
US |
|
N
|
Nexters Inc
NASDAQ:GDEV
|
VG |
|
Fastenal Co
NASDAQ:FAST
|
US |
|
K
|
Ksolves India Ltd
NSE:KSOLVES
|
IN |
|
R
|
Rostelekom PAO
MOEX:RTKM
|
RU |
|
Sunoco LP
NYSE:SUN
|
US |
|
Confinvest FL SpA
MIL:CFV
|
IT |
|
G
|
Grenergy Renovables SA
MAD:GRE
|
ES |
Wall Street
Price Targets
TECH Price Targets Summary
Bio-Techne Corp
According to Wall Street analysts, the average 1-year price target for
TECH
is 76.73 USD
with a low forecast of 65.65 USD and a high forecast of 84 USD.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.
What is TECH's stock price target?
Price Target
76.73
USD
According to Wall Street analysts, the average 1-year price target for
TECH
is 76.73 USD
with a low forecast of 65.65 USD and a high forecast of 84 USD.
What is Bio-Techne Corp's Revenue forecast?
Projected CAGR
6%
For the last 13 years the
compound annual growth rate for
Bio-Techne Corp's revenue is
11%.
The projected
CAGR
for the next 3 years is
6%.
What is Bio-Techne Corp's Operating Income forecast?
Projected CAGR
24%
For the last 13 years the
compound annual growth rate for
Bio-Techne Corp's operating income is
3%.
The projected
CAGR
for the next 3 years is
24%.
What is Bio-Techne Corp's Net Income forecast?
Projected CAGR
76%
For the last 13 years the
compound annual growth rate for
Bio-Techne Corp's net income is
-3%.
The projected
CAGR
for the next 3 years is
76%.
